SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $46,663,000 | +276.4% | 293,384 | +126.7% | 0.06% | +235.3% |
Q4 2018 | $12,398,000 | -70.0% | 129,430 | -55.7% | 0.02% | -32.0% |
Q3 2018 | $41,278,000 | +68.4% | 292,236 | +86.6% | 0.02% | -19.4% |
Q2 2018 | $24,511,000 | -37.0% | 156,587 | -35.2% | 0.03% | -38.0% |
Q1 2018 | $38,913,000 | +71.6% | 241,588 | +75.5% | 0.05% | +72.4% |
Q4 2017 | $22,677,000 | +183.5% | 137,679 | +7.2% | 0.03% | +163.6% |
Q3 2017 | $8,000,000 | -23.1% | 128,413 | -1.7% | 0.01% | -26.7% |
Q2 2017 | $10,407,000 | +24.0% | 130,677 | +10.7% | 0.02% | +25.0% |
Q1 2017 | $8,391,000 | +233.4% | 118,072 | +139.5% | 0.01% | +200.0% |
Q4 2016 | $2,517,000 | +27.5% | 49,296 | +15.0% | 0.00% | +33.3% |
Q3 2016 | $1,974,000 | +52.8% | 42,877 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $1,292,000 | +80.2% | 42,877 | +91.6% | 0.00% | +100.0% |
Q1 2016 | $717,000 | -40.5% | 22,373 | +8.2% | 0.00% | -50.0% |
Q4 2015 | $1,206,000 | +39.3% | 20,679 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $866,000 | -40.7% | 20,474 | +2.3% | 0.00% | -33.3% |
Q2 2015 | $1,461,000 | +268.0% | 20,015 | +153.1% | 0.00% | +200.0% |
Q1 2015 | $397,000 | +41.3% | 7,909 | +3.0% | 0.00% | 0.0% |
Q4 2014 | $281,000 | +66.3% | 7,681 | +43.3% | 0.00% | – |
Q3 2014 | $169,000 | – | 5,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |